Study for the relationship and mechanism between Dickkopf-3 and in-stent restenosis of coronary artery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025916

Enrollment

Unknown

Registered

2019-09-14

Start date

2019-10-31

Completion date

Unknown

Last updated

2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in-stent restenosis of coronary artery

Interventions

Case series:N//A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Drug-eluting stents were implanted for the first time; 2. Coronary angiography was performed from 6 to 12 months after operation; 3. Double antiplatelet agents (aspirin 100 mg/day, clopidogrel 75 mg/day or tegrilol 180 mg/day) were taken routinely after operation.

Exclusion criteria

Exclusion criteria: Patients with a total occluded artery or acute myocardial infarction were excluded.

Design outcomes

Primary

Measure	Time frame
To observe the expression of microRNAs from plasma;	—

Countries

China

Contacts

Public ContactYan Gaoliang

Department of Cardiology, Zhongda Hospital of Southeast University Medical School

yan_seu@hotmail.com+86 18761890380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026